Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Cavallini, G; Frulloni, L
   Somatostatin and octreotide in acute pancreatitis: the never-ending story
   DIGESTIVE AND LIVER DISEASE
   
   G. Cavallini e L. Frulloni, "Somatostatin and octreotide in acute pancreatitis: the never-ending story", DIG LIVER D, 33(2), 2001, pp. 192-201
2. Frohman, LA
   Pituitary tumors in pregnancy
   ENDOCRINOLOGIST
   
   L.A. Frohman, "Pituitary tumors in pregnancy", ENDOCRINOLO, 11(5), 2001, pp. 399-406
3. Hastier, P
   Can post-ERCP acute pancreatitis be predicted and prevented?
   GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
   
   P. Hastier, "Can post-ERCP acute pancreatitis be predicted and prevented?", GASTRO CL B, 25(1), 2001, pp. S140-S150
4. Heyries, L
   ERCP-induced pancreatitis: risk factors and prophylactic treatment
   GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
   
   L. Heyries, "ERCP-induced pancreatitis: risk factors and prophylactic treatment", GASTRO CL B, 25(1), 2001, pp. S241-S246
5. Carlton, SM; Du, JH; Davidson, E; Zhou, ST; Coggeshall, RE
   Somatostatin receptors on peripheral primary afferent terminals: inhibition of sensitized nociceptors
   PAIN
   
   S.M. Carlton et al., "Somatostatin receptors on peripheral primary afferent terminals: inhibition of sensitized nociceptors", PAIN, 90(3), 2001, pp. 233-244
6. Ortuno, FM; Alfonso, AMP; Martinez, JGM; Escribano, JRD; Paya, VEC; Rocamora, JP; Garri, FS
   Biventricular impairment in diastolic function in acromegaly
   REVISTA ESPANOLA DE CARDIOLOGIA
   
   F.M. Ortuno et al., "Biventricular impairment in diastolic function in acromegaly", REV ESP CAR, 54(1), 2001, pp. 37-42
7. Minniti, G; Moroni, C; Jaffrain-Rea, ML; Esposito, V; Santoro, A; Affricano, C; Cantore, G; Tamburrano, G; Cassone, R
   Marked improvement in cardiovascular function after successful transsphenoidal surgery in acromegalic patients
   CLINICAL ENDOCRINOLOGY
   
   G. Minniti et al., "Marked improvement in cardiovascular function after successful transsphenoidal surgery in acromegalic patients", CLIN ENDOCR, 55(3), 2001, pp. 307-313
8. Fassnacht, M; Capeller, B; Arlt, W; Steck, T; Allolio, B
   Octreotide LAR (R) treatment throughout pregnancy in an acromegalic woman
   CLINICAL ENDOCRINOLOGY
   
   M. Fassnacht et al., "Octreotide LAR (R) treatment throughout pregnancy in an acromegalic woman", CLIN ENDOCR, 55(3), 2001, pp. 411-415
9. Colao, A; Spiezia, S; Cerbone, G; Pivonello, R; Marzullo, P; Ferone, D; Di Somma, C; Assanti, AP; Lombardi, G
   Increased arterial intima-media thickness by B-M mode echodoppler ultrasonography in acromegaly
   CLINICAL ENDOCRINOLOGY
   
   A. Colao et al., "Increased arterial intima-media thickness by B-M mode echodoppler ultrasonography in acromegaly", CLIN ENDOCR, 54(4), 2001, pp. 515-524
10. Colao, A; Marzullo, P; Di Somma, C; Lombardi, G
    Growth hormone and the heart
    CLINICAL ENDOCRINOLOGY
    
    A. Colao et al., "Growth hormone and the heart", CLIN ENDOCR, 54(2), 2001, pp. 137-154
11. Testoni, PA; Bagnolo, F; Andriulli, A; Bernasconi, G; Crotta, S; Lella, F; Lomazzi, A; Minoli, G; Natale, C; Prada, A; Toti, GL; Zambelli, A
    Octreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis: results of a multicenter, randomized, controlled trial
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    
    P.A. Testoni et al., "Octreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis: results of a multicenter, randomized, controlled trial", ALIM PHARM, 15(7), 2001, pp. 965-972
12. Zalatnai, A; Pogany, V
    Apoptosis-induction and phosphorylation state in human pancreatic carcinoma xenografts following octreotide treatment
    ANTICANCER RESEARCH
    
    A. Zalatnai e V. Pogany, "Apoptosis-induction and phosphorylation state in human pancreatic carcinoma xenografts following octreotide treatment", ANTICANC R, 21(1A), 2001, pp. 477-480
13. Jane, JA; Thapar, K; Laws, ER
    Acromegaly: historical perspectives and current therapy
    JOURNAL OF NEURO-ONCOLOGY
    
    J.A. Jane et al., "Acromegaly: historical perspectives and current therapy", J NEURO-ONC, 54(2), 2001, pp. 129-137
14. Colao, A; Cuocolo, A; Marzullo, P; Nicolai, E; Ferone, D; Morte, AMD; Pivonello, R; Salvatore, M; Lombardi, G
    Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance
    JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    
    A. Colao et al., "Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance", J CLIN END, 86(4), 2001, pp. 1551-1557
15. Losa, M; Ciccarelli, E; Mortini, P; Barzaghi, R; Gaia, D; Faccani, G; Papotti, M; Mangili, F; Terreni, MR; Camanni, F; Giovanelli, M
    Effects of octreotide treatment on the proliferation and apoptotic index of GH-secreting pituitary adenomas
    JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    
    M. Losa et al., "Effects of octreotide treatment on the proliferation and apoptotic index of GH-secreting pituitary adenomas", J CLIN END, 86(11), 2001, pp. 5194-5200
16. Budzynska, A; Marek, T; Nowak, A; Kaczor, R; Nowakovska-Dulawa, E
    A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis
    ENDOSCOPY
    
    A. Budzynska et al., "A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis", ENDOSCOPY, 33(9), 2001, pp. 766-772
17. Oberg, K
    Established clinical use of octreotide and lanreotide in oncology
    CHEMOTHERAPY
    
    K. Oberg, "Established clinical use of octreotide and lanreotide in oncology", CHEMOTHERA, 47, 2001, pp. 40-53
18. Kouroumalis, EA
    Octreotide for cancer of the liver and biliary tree
    CHEMOTHERAPY
    
    E.A. Kouroumalis, "Octreotide for cancer of the liver and biliary tree", CHEMOTHERA, 47, 2001, pp. 150-161
19. Liote, F; Orcel, P
    Osteoarticular disorders of endocrine origin
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    
    F. Liote e P. Orcel, "Osteoarticular disorders of endocrine origin", BEST PR R C, 14(2), 2000, pp. 251-276
20. Brickman, WJ; Silverman, BL
    Cardiovascular effects of growth hormone
    ENDOCRINE
    
    W.J. Brickman e B.L. Silverman, "Cardiovascular effects of growth hormone", ENDOCRINE, 12(2), 2000, pp. 153-161
21. Oberg, K
    State of the art and future prospects in the management of neuroendocrine tumors
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    
    K. Oberg, "State of the art and future prospects in the management of neuroendocrine tumors", Q J NUCL M, 44(1), 2000, pp. 3-12
22. Beckman, RA; Siden, R; Yanik, GA; Levine, JE
    Continuous octreotide infusion for the treatment of secretory diarrhea caused by acute intestinal graft-versus-host disease in a child
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    
    R.A. Beckman et al., "Continuous octreotide infusion for the treatment of secretory diarrhea caused by acute intestinal graft-versus-host disease in a child", J PED H ONC, 22(4), 2000, pp. 344-350
23. Huang, CM; Wu, YT; Chen, ST
    Targeting delivery of paclitaxel into tumor cells via somatostatin receptor endocytosis
    CHEMISTRY & BIOLOGY
    
    C.M. Huang et al., "Targeting delivery of paclitaxel into tumor cells via somatostatin receptor endocytosis", CHEM BIOL, 7(7), 2000, pp. 453-461
24. Stefaneanu, L; Kovacs, K; Thapar, K; Horvath, E; Melmed, S; Greenman, Y
    Octreotide effect on growth hormone and somatostatin subtype 2 receptor mRNAs of the human pituitary somatotroph adenomas
    ENDOCRINE PATHOLOGY
    
    L. Stefaneanu et al., "Octreotide effect on growth hormone and somatostatin subtype 2 receptor mRNAs of the human pituitary somatotroph adenomas", ENDOCR PATH, 11(1), 2000, pp. 41-48
25. Kondo, H; Takino, H; Akino, K; Yamasaki, H; Yamaguchi, Y; Ito, M; Eguchi, K
    Octreotide treatment suppresses malignant somatotrophic pituitary tumor cell growth in rats
    ONCOLOGY REPORTS
    
    H. Kondo et al., "Octreotide treatment suppresses malignant somatotrophic pituitary tumor cell growth in rats", ONCOL REP, 7(5), 2000, pp. 965-969
26. Bakke, I; Sandvik, AK; Waldum, HL
    Octreotide inhibits the enterochromaffin-like cell but not peroxisome proliferator-induced hypergastrinemia
    JOURNAL OF MOLECULAR ENDOCRINOLOGY
    
    I. Bakke et al., "Octreotide inhibits the enterochromaffin-like cell but not peroxisome proliferator-induced hypergastrinemia", J MOL ENDOC, 25(1), 2000, pp. 109-119
27. Kornblau, S; Benson, AB; Catalano, R; Champlin, RE; Engelking, C; Field, M; Ippoliti, C; Lazarus, HM; Mitchell, E; Rubin, J; Stiff, PJ; Vokes, E; Wadler, S
    Management of cancer treatment-related diarrhea: Issues and therapeutic strategies
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
    
    S. Kornblau et al., "Management of cancer treatment-related diarrhea: Issues and therapeutic strategies", J PAIN SYMP, 19(2), 2000, pp. 118-129
28. Turhal, NS; Bruckner, HW
    Pancreatic duct cell carcinoma with positive In-111 octreotide uptake
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    
    N.S. Turhal e H.W. Bruckner, "Pancreatic duct cell carcinoma with positive In-111 octreotide uptake", J EXP CL C, 19(2), 2000, pp. 241-244
29. Colao, A; Di Sarno, A; Marzullo, P; Di Somma, C; Cerbone, G; Landi, ML; Faggiano, A; Merola, B; Lombardi, G
    New medical approaches in pituitary adenomas
    HORMONE RESEARCH
    
    A. Colao et al., "New medical approaches in pituitary adenomas", HORMONE RES, 53, 2000, pp. 76-87
30. Chatila, R; Ferayorni, L; Gupta, T; Groszmann, RJ
    Local arterial vasoconstriction induced by octreotide in patients with cirrhosis
    HEPATOLOGY
    
    R. Chatila et al., "Local arterial vasoconstriction induced by octreotide in patients with cirrhosis", HEPATOLOGY, 31(3), 2000, pp. 572-576
31. Zalatnai, A; Szegedi, Z; Bocsi, J
    Flow cytometric evidence of apoptosis in human pancreatic cancer xenografts treated with sandostatin (octreotide)
    ANTICANCER RESEARCH
    
    A. Zalatnai et al., "Flow cytometric evidence of apoptosis in human pancreatic cancer xenografts treated with sandostatin (octreotide)", ANTICANC R, 20(3A), 2000, pp. 1663-1666
32. Vitale, G; Tagliaferri, P; Caraglia, M; Rampone, E; Ciccarelli, A; Bianco, AR; Abbruzzese, A; Lupoli, G
    Slow release lanreotide in combination with interferon-alpha 2b in the treatment of symptomatic advanced medullary thyroid carcinoma
    JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    
    G. Vitale et al., "Slow release lanreotide in combination with interferon-alpha 2b in the treatment of symptomatic advanced medullary thyroid carcinoma", J CLIN END, 85(3), 2000, pp. 983-988
33. Pascual, J
    Headache relief after sumatriptan in a patient with pituitary macroadenoma
    HEADACHE
    
    J. Pascual, "Headache relief after sumatriptan in a patient with pituitary macroadenoma", HEADACHE, 40(5), 2000, pp. 399-399
34. Andriulli, A; Leandro, G; Niro, G; Mangia, A; Festa, V; Gambassi, G; Villani, MR; Facciorusso, D; Conoscitore, P; Spirito, F; De Maio, G
    Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis
    GASTROINTESTINAL ENDOSCOPY
    
    A. Andriulli et al., "Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis", GASTROIN EN, 51(1), 2000, pp. 1-7
35. Orrego, JJ; Barkan, AL
    Pituitary disorders - Drug treatment options
    DRUGS
    
    J.J. Orrego e A.L. Barkan, "Pituitary disorders - Drug treatment options", DRUGS, 59(1), 2000, pp. 93-106
36. O'Toole, D; Ducreux, M; Bommelaer, G; Wemeau, JL; Bouche, O; Catus, F; Blumberg, J; Ruszniewski, P
    Treatment of carcinoid syndrome - A prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, andtolerance
    CANCER
    
    D. O'Toole et al., "Treatment of carcinoid syndrome - A prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, andtolerance", CANCER, 88(4), 2000, pp. 770-776
37. Baykal, A; Ozdemir, A; Renda, N; Korkmaz, A; Sayek, I
    The effect of octreotide on postoperative adhesion formation
    CANADIAN JOURNAL OF SURGERY
    
    A. Baykal et al., "The effect of octreotide on postoperative adhesion formation", CAN J SURG, 43(1), 2000, pp. 43-47
38. Lawnicka, H; Stepien, H; Wyczolkowska, J; Kolago, B; Kunert-Radek, J; Komorowski, J
    Effect of somatostatin and octreotide on proliferation and vascular endothelial growth factor secretion from murine endothelial cell line (HECa10) culture
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    
    H. Lawnicka et al., "Effect of somatostatin and octreotide on proliferation and vascular endothelial growth factor secretion from murine endothelial cell line (HECa10) culture", BIOC BIOP R, 268(2), 2000, pp. 567-571
39. Lombardi, G; Di Somma, C; Marzullo, P; Cerbone, G; Colao, A
    Growth hormone and cardiac function
    ANNALES D ENDOCRINOLOGIE
    
    G. Lombardi et al., "Growth hormone and cardiac function", ANN ENDOCR, 61(1), 2000, pp. 16-21
40. Maselli, MA; Piepoli, AL; Pezzolla, F; Caruso, ML; Lorusso, D
    Effect of somatostatin on human gallbladder motility: an in vitro study
    NEUROGASTROENTEROLOGY AND MOTILITY
    
    M.A. Maselli et al., "Effect of somatostatin on human gallbladder motility: an in vitro study", NEUROG MOT, 11(1), 1999, pp. 47-53
41. Laursen, T; Moller, J; Fisker, S; Jorgensen, JOL; Christiansen, JS
    Effects of a 7-day continuous infusion of octreotide on circulating levelsof growth factors and binding proteins in growth hormone (GH)-treated GH-deficient patients
    GROWTH HORMONE & IGF RESEARCH
    
    T. Laursen et al., "Effects of a 7-day continuous infusion of octreotide on circulating levelsof growth factors and binding proteins in growth hormone (GH)-treated GH-deficient patients", GROWTH H I, 9(6), 1999, pp. 451-457
42. Verschraegen, CF; Matei, C; Loyer, E; Malpica, A; Tornos, C; Kudelka, AP; Kavanagh, JJ
    Octreotide induced remission of a refractory small cell carcinoma of the endometrium
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    
    C.F. Verschraegen et al., "Octreotide induced remission of a refractory small cell carcinoma of the endometrium", INT J GYN C, 9(1), 1999, pp. 80-85
43. Shomali, ME; Katznelson, L
    Medical therapy for gonadotroph and thyrotroph tumors
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
    
    M.E. Shomali e L. Katznelson, "Medical therapy for gonadotroph and thyrotroph tumors", END METAB C, 28(1), 1999, pp. 223
44. Bozzola, M; Radetti, G; Buzi, F; Tonini, G; Moretta, A; Autelli, M; Aglialoro, A; Rondini, G; Barreca, A
    Growth hormone bioactivity and immunoactivity in tall children
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    
    M. Bozzola et al., "Growth hormone bioactivity and immunoactivity in tall children", J ENDOC INV, 22(7), 1999, pp. 541-546
45. Karakoyunlar, O; Sivrel, E; Tanir, N; Denecli, AG
    High dose octreotide in the management of acute pancreatitis
    HEPATO-GASTROENTEROLOGY
    
    O. Karakoyunlar et al., "High dose octreotide in the management of acute pancreatitis", HEP-GASTRO, 46(27), 1999, pp. 1968-1972
46. Baiocchi, L; LeSage, G; Glaser, S; Alpini, G
    Regulation of cholangiocyte bile secretion
    JOURNAL OF HEPATOLOGY
    
    L. Baiocchi et al., "Regulation of cholangiocyte bile secretion", J HEPATOL, 31(1), 1999, pp. 179-191
47. Rauca, C; Schafer, K; Hollt, V
    Effects of somatostatin, octreotide and cortistatin on ischaemic neuronal damage following permanent middle cerebral artery occlusion in the rat
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    
    C. Rauca et al., "Effects of somatostatin, octreotide and cortistatin on ischaemic neuronal damage following permanent middle cerebral artery occlusion in the rat", N-S ARCH PH, 360(6), 1999, pp. 633-638
48. Colao, A; Cuocolo, A; Marzullo, P; Nicolai, E; Ferone, D; Della Morte, AM; Petretta, M; Salvatore, M; Lombardi, G
    Impact of patient's age and disease duration on cardiac performance in acromegaly: A radionuclide angiography study
    JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    
    A. Colao et al., "Impact of patient's age and disease duration on cardiac performance in acromegaly: A radionuclide angiography study", J CLIN END, 84(5), 1999, pp. 1518-1523
49. Colao, A; Cuocolo, A; Marzullo, P; Nicolai, E; Ferone, D; Florimonte, L; Salvatore, M; Lombardi, G
    Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly
    JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    
    A. Colao et al., "Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly", J CLIN END, 84(1), 1999, pp. 17-23
50. Kotrlik, J
    Octreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography
    GASTROINTESTINAL ENDOSCOPY
    
    J. Kotrlik, "Octreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography", GASTROIN EN, 50(5), 1999, pp. 728-729
51. Poon, RTP; Yeung, C; Lo, CM; Yuen, WK; Liu, CL; Fan, ST
    Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial
    GASTROINTESTINAL ENDOSCOPY
    
    R.T.P. Poon et al., "Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial", GASTROIN EN, 49(5), 1999, pp. 593-598
52. Morris, RS; Karande, VC; Dudkiewicz, A; Morris, JL; Gleicher, N
    Octreotide is not useful for clomiphene citrate resistance in patients with polycystic ovary syndrome but may reduce the likelihood of ovarian hyperstimulation syndrome
    FERTILITY AND STERILITY
    
    R.S. Morris et al., "Octreotide is not useful for clomiphene citrate resistance in patients with polycystic ovary syndrome but may reduce the likelihood of ovarian hyperstimulation syndrome", FERT STERIL, 71(3), 1999, pp. 452-456
53. Faiss, S; Rath, U; Mansmann, U; Caird, D; Clemens, N; Riecken, EO; Wiedenmann, B
    Ultra-high-dose lanreotide treatment in patients with metastatic neuroendocrine gastroenteropancreatic tumors
    DIGESTION
    
    S. Faiss et al., "Ultra-high-dose lanreotide treatment in patients with metastatic neuroendocrine gastroenteropancreatic tumors", DIGESTION, 60(5), 1999, pp. 469-476
54. Degen, L; Beglinger, C
    The role of octreotide in the treatment of gastroenteropancreatic endocrine tumors
    DIGESTION
    
    L. Degen e C. Beglinger, "The role of octreotide in the treatment of gastroenteropancreatic endocrine tumors", DIGESTION, 60, 1999, pp. 9-14
55. Uhl, W; Anghelacopoulos, SE; Friess, H; Buchler, MW
    The role of octreotide and somatostatin in acute and chronic pancreatitis
    DIGESTION
    
    W. Uhl et al., "The role of octreotide and somatostatin in acute and chronic pancreatitis", DIGESTION, 60, 1999, pp. 23-30
56. Fried, M
    Octreotide in the treatment of refractory diarrhea
    DIGESTION
    
    M. Fried, "Octreotide in the treatment of refractory diarrhea", DIGESTION, 60, 1999, pp. 42-46
57. Ko, CW; Sekijima, JH; Lee, SP
    Biliary sludge
    ANNALS OF INTERNAL MEDICINE
    
    C.W. Ko et al., "Biliary sludge", ANN INT MED, 130(4), 1999, pp. 301-311
58. Testoni, PA; Bagnolo, F; Caporuscio, S; Lella, F
    Serum amylase measured four hours after endoscopic sphincterotomy is a reliable predictor of postprocedure pancreatitis
    AMERICAN JOURNAL OF GASTROENTEROLOGY
    
    P.A. Testoni et al., "Serum amylase measured four hours after endoscopic sphincterotomy is a reliable predictor of postprocedure pancreatitis", AM J GASTRO, 94(5), 1999, pp. 1235-1241
59. De Palma, GD; Catanzano, C
    Use of corticosteroids in the prevention of post-ERCP pancreatitis: Results of a controlled prospective study
    AMERICAN JOURNAL OF GASTROENTEROLOGY
    
    G.D. De Palma e C. Catanzano, "Use of corticosteroids in the prevention of post-ERCP pancreatitis: Results of a controlled prospective study", AM J GASTRO, 94(4), 1999, pp. 982-985
60. Mayinger, B; Axelos, D; Pavel, M; Hahn, EG; Hensen, J
    Monosymptomatic hyperthyroidism and TSH-producing adenoma: successful treatment with octreotide
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    
    B. Mayinger et al., "Monosymptomatic hyperthyroidism and TSH-producing adenoma: successful treatment with octreotide", DEUT MED WO, 124(4), 1999, pp. 73-78
61. MCCARTHY KE; WOLTERING EA; ESPENAN GD; CRONIN M; MALONEY TJ; ANTHONY LB
    IN-SITU RADIOTHERAPY WITH IN-111-PENTETREOTIDE - INITIAL OBSERVATIONSAND FUTURE-DIRECTIONS
    The cancer journal from Scientific American
    
    K.E. Mccarthy et al., "IN-SITU RADIOTHERAPY WITH IN-111-PENTETREOTIDE - INITIAL OBSERVATIONSAND FUTURE-DIRECTIONS", The cancer journal from Scientific American, 4(2), 1998, pp. 94-102
62. IPPOLITI C
    ANTIDIARRHEAL AGENTS FOR THE MANAGEMENT OF TREATMENT-RELATED DIARRHEAIN CANCER-PATIENTS
    American journal of health-system pharmacy
    
    C. Ippoliti, "ANTIDIARRHEAL AGENTS FOR THE MANAGEMENT OF TREATMENT-RELATED DIARRHEAIN CANCER-PATIENTS", American journal of health-system pharmacy, 55(15), 1998, pp. 1573-1580
63. PINZONE JJ; KATZNELSON L; KLIBANSKI A
    ACROMEGALIC HEART-DISEASE
    The Endocrinologist
    
    J.J. Pinzone et al., "ACROMEGALIC HEART-DISEASE", The Endocrinologist, 8(4), 1998, pp. 273-278
64. FALLO F; BARZON L; BOSCARO M; CASIGLIA E; SONINO N
    EFFECT OF OCTREOTIDE ON 24-H BLOOD-PRESSURE PROFILE IN ACROMEGALY
    American journal of hypertension
    
    F. Fallo et al., "EFFECT OF OCTREOTIDE ON 24-H BLOOD-PRESSURE PROFILE IN ACROMEGALY", American journal of hypertension, 11(5), 1998, pp. 591-596
65. MILLAT B; BORIE F; GUILLON F
    RANDOMIZED TRIALS IN THE TREATMENT OF ACU TE-PANCREATITIS
    Gastroenterologie clinique et biologique
    
    B. Millat et al., "RANDOMIZED TRIALS IN THE TREATMENT OF ACU TE-PANCREATITIS", Gastroenterologie clinique et biologique, 22(1), 1998, pp. 29-39
66. Chanson, P; Megnien, JL; del Pino, M; Coirault, C; Merli, I; Houdouin, L; Harris, AG; Levenson, J; Lecarpentier, Y; Simon, A; Chemla, D
    Decreased regional blood flow in patients with acromegaly
    CLINICAL ENDOCRINOLOGY
    
    P. Chanson et al., "Decreased regional blood flow in patients with acromegaly", CLIN ENDOCR, 49(6), 1998, pp. 725-731
67. Tulassay, Z; Dobronte, Z; Pronai, L; Zagoni, T; Juhasz, L
    Octreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    
    Z. Tulassay et al., "Octreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography.", ALIM PHARM, 12(11), 1998, pp. 1109-1112
68. Marton, J; Szasz, Z; Nagy, Z; Jarmay, K; Takacs, T; Lonovics, J; Balogh, A; Farkas, G
    Beneficial effect of octreotide treatment in acute pancreatitis in rats
    INTERNATIONAL JOURNAL OF PANCREATOLOGY
    
    J. Marton et al., "Beneficial effect of octreotide treatment in acute pancreatitis in rats", INT J PANCR, 24(3), 1998, pp. 203-210
69. HENGST K; NASHAN B; AVENHAUS W; ULLERICH H; SCHLITT HJ; FLEMMING P; PICHLMAYR R; DOMSCHKE W
    METASTATIC PANCREATIC VIPOMA - DETERIORATING CLINICAL COURSE AND SUCCESSFUL TREATMENT BY LIVER-TRANSPLANTATION
    Zeitschrift fur Gastroenterologie
    
    K. Hengst et al., "METASTATIC PANCREATIC VIPOMA - DETERIORATING CLINICAL COURSE AND SUCCESSFUL TREATMENT BY LIVER-TRANSPLANTATION", Zeitschrift fur Gastroenterologie, 36(3), 1998, pp. 239-245
70. Tulassay, Z
    Somatostatin and the gastrointestinal tract
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    
    Z. Tulassay, "Somatostatin and the gastrointestinal tract", SC J GASTR, 33, 1998, pp. 115-121
71. DEMIRTAS E; SAG C; KURSAKLIOGLU H; UZUN M; UZBAY T; TORE HF; KOSE S; GENC C; DEMIRKAN D
    EFFECTS OF OCTREOTIDE IN PATIENTS WITH HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    Japanese Heart Journal
    
    E. Demirtas et al., "EFFECTS OF OCTREOTIDE IN PATIENTS WITH HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY", Japanese Heart Journal, 39(2), 1998, pp. 173-181
72. Otsuka, F; Kageyama, J; Ogura, T; Makino, H
    Cluster headache dependent upon octreotide injection
    HEADACHE
    
    F. Otsuka et al., "Cluster headache dependent upon octreotide injection", HEADACHE, 38(8), 1998, pp. 629-629
73. BORDAS JM; TOLEDOPIMENTEL V; LLACH J; ELENA M; MONDELO F; GINES A; TERES J
    EFFECTS OF BOLUS SOMATOSTATIN IN PREVENTING PANCREATITIS AFTER ENDOSCOPIC PANCREATOGRAPHY - RESULTS OF A RANDOMIZED STUDY
    Gastrointestinal endoscopy
    
    J.M. Bordas et al., "EFFECTS OF BOLUS SOMATOSTATIN IN PREVENTING PANCREATITIS AFTER ENDOSCOPIC PANCREATOGRAPHY - RESULTS OF A RANDOMIZED STUDY", Gastrointestinal endoscopy, 47(3), 1998, pp. 230-234
74. HUANG JQ; PADBURY RTA; SCHLOITHE AC; COX MR; SIMULA ME; HARVEY JR; BAKER RA; TOOULI J; SACCONE GTP
    SOMATOSTATIN STIMULATES THE BRUSH-TAILED POSSUM SPHINCTER OF ODDI IN-VITRO AND IN-VIVO
    Gastroenterology
    
    J.Q. Huang et al., "SOMATOSTATIN STIMULATES THE BRUSH-TAILED POSSUM SPHINCTER OF ODDI IN-VITRO AND IN-VIVO", Gastroenterology, 115(3), 1998, pp. 672-679
75. MEHTA SN; PAVONE E; BARKUN JS; BOUCHARD S; BARKUN AN
    PREDICTORS OF POST-ERCP COMPLICATIONS IN PATIENTS WITH SUSPECTED CHOLEDOCHOLITHIASIS
    Endoscopy (Stuttgart)
    
    S.N. Mehta et al., "PREDICTORS OF POST-ERCP COMPLICATIONS IN PATIENTS WITH SUSPECTED CHOLEDOCHOLITHIASIS", Endoscopy (Stuttgart), 30(5), 1998, pp. 457-463
76. DUMOT JA; CONWELL DL; OCONNOR JB; FERGUSON DR; VARGO JJ; BARNES DS; SHAY SS; STERLING MJ; HORTH KS; ISSA K; PONSKY JL; ZUCCARO G
    PRETREATMENT WITH METHYLPREDNISOLONE TO PREVENT ERCP-INDUCED PANCREATITIS - A RANDOMIZED, MULTICENTER, PLACEBO-CONTROLLED CLINICAL-TRIAL
    The American journal of gastroenterology
    
    J.A. Dumot et al., "PRETREATMENT WITH METHYLPREDNISOLONE TO PREVENT ERCP-INDUCED PANCREATITIS - A RANDOMIZED, MULTICENTER, PLACEBO-CONTROLLED CLINICAL-TRIAL", The American journal of gastroenterology, 93(1), 1998, pp. 61-65
77. NISHIKI M; MURAKAMI Y; SOHMIYA M; KOSHIMURA K; INOUE K; GOTO Y; NAKAMURA N; KATO Y
    HISTOPATHOLOGICAL IMPROVEMENT OF ACROMEGALIC CARDIOMYOPATHY BY INTERMITTENT SUBCUTANEOUS INFUSION OF OCTREOTIDE
    Endocrine journal
    
    M. Nishiki et al., "HISTOPATHOLOGICAL IMPROVEMENT OF ACROMEGALIC CARDIOMYOPATHY BY INTERMITTENT SUBCUTANEOUS INFUSION OF OCTREOTIDE", Endocrine journal, 44(5), 1997, pp. 655-660
78. BORDET R; VERWAERDE P; TRAN MA; MARQUES MA; MONTASTRUC JL; SENARD JM
    EFFECTS OF OCTREOTIDE ON EXPERIMENTAL NEUROGENIC ORTHOSTATIC HYPOTENSION IN ANESTHETIZED DOGS
    Fundamental and clinical pharmacology
    
    R. Bordet et al., "EFFECTS OF OCTREOTIDE ON EXPERIMENTAL NEUROGENIC ORTHOSTATIC HYPOTENSION IN ANESTHETIZED DOGS", Fundamental and clinical pharmacology, 11(3), 1997, pp. 237-244
79. MATHIAS CJ
    PHARMACOLOGICAL MANIPULATION OF HUMAN GASTROINTESTINAL BLOOD-FLOW
    Fundamental and clinical pharmacology
    
    C.J. Mathias, "PHARMACOLOGICAL MANIPULATION OF HUMAN GASTROINTESTINAL BLOOD-FLOW", Fundamental and clinical pharmacology, 11(1), 1997, pp. 29-34
80. OZBEY N; ONCUL A; BUGRA Z; VURAL A; ERZENGIN F; ORHAN Y; BUYUKOZTURK K; SENCER E; MOLVALILAR S
    ACROMEGALIC CARDIOMYOPATHY - EVALUATION OF THE LEFT-VENTRICULAR DIASTOLIC FUNCTION IN THE SUBCLINICAL STAGE
    Journal of endocrinological investigation
    
    N. Ozbey et al., "ACROMEGALIC CARDIOMYOPATHY - EVALUATION OF THE LEFT-VENTRICULAR DIASTOLIC FUNCTION IN THE SUBCLINICAL STAGE", Journal of endocrinological investigation, 20(6), 1997, pp. 305-311
81. LOMBARDI G; COLAO A; CUOCOLO A; LONGOBARDI S; DISOMMA C; ORIO F; MEROLA B; NICOLAI E; SALVATORE M
    CARDIOLOGICAL ASPECTS OF GROWTH-HORMONE AND INSULIN-LIKE GROWTH-FACTOR-I
    Journal of pediatric endocrinology & metabolism
    
    G. Lombardi et al., "CARDIOLOGICAL ASPECTS OF GROWTH-HORMONE AND INSULIN-LIKE GROWTH-FACTOR-I", Journal of pediatric endocrinology & metabolism, 10(6), 1997, pp. 553-560
82. WASSERMAN E; HIDALGO M; HORNEDO J; CORTESFUNES H
    OCTREOTIDE (SMS 201-995) FOR HEMATOPOIETIC SUPPORT-DEPENDENT HIGH-DOSE CHEMOTHERAPY (HSD-HDC)-RELATED DIARRHEA - DOSE-FINDING STUDY AND EVALUATION OF EFFICACY
    Bone marrow transplantation
    
    E. Wasserman et al., "OCTREOTIDE (SMS 201-995) FOR HEMATOPOIETIC SUPPORT-DEPENDENT HIGH-DOSE CHEMOTHERAPY (HSD-HDC)-RELATED DIARRHEA - DOSE-FINDING STUDY AND EVALUATION OF EFFICACY", Bone marrow transplantation, 20(9), 1997, pp. 711-714
83. VECHT J; MASCLEE AAM; LAMERS CBHW
    THE DUMPING SYNDROME - CURRENT INSIGHTS INTO PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT
    Scandinavian journal of gastroenterology
    
    J. Vecht et al., "THE DUMPING SYNDROME - CURRENT INSIGHTS INTO PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT", Scandinavian journal of gastroenterology, 32, 1997, pp. 21-27
84. LIUZZI A; OPPIZZI G
    PANEL DISCUSSION PAPER - EVIDENCE FOR OCTREOTIDE SUBCUTANEOUSLY IN THE TREATMENT OF ACROMEGALY
    Journal of Endocrinology
    
    A. Liuzzi e G. Oppizzi, "PANEL DISCUSSION PAPER - EVIDENCE FOR OCTREOTIDE SUBCUTANEOUSLY IN THE TREATMENT OF ACROMEGALY", Journal of Endocrinology, 155, 1997, pp. 61-65
85. CARON P; BUSCAIL L; BECKERS A; ESTEVE JP; IGOUT A; HENNEN G; SUSINI C
    EXPRESSION OF SOMATOSTATIN RECEPTOR SST4 IN HUMAN PLACENTA AND ABSENCE OF OCTREOTIDE EFFECT ON HUMAN PLACENTAL GROWTH-HORMONE CONCENTRATIONDURING PREGNANCY
    The Journal of clinical endocrinology and metabolism
    
    P. Caron et al., "EXPRESSION OF SOMATOSTATIN RECEPTOR SST4 IN HUMAN PLACENTA AND ABSENCE OF OCTREOTIDE EFFECT ON HUMAN PLACENTAL GROWTH-HORMONE CONCENTRATIONDURING PREGNANCY", The Journal of clinical endocrinology and metabolism, 82(11), 1997, pp. 3771-3776
86. COLAO A; FERONE D; CAPPABIANCA P; DECARO MLD; MARZULLO P; MONTICELLI A; ALFIERI A; MEROLA B; CALI A; DEDIVITIIS E; LOMBARDI G
    EFFECT OF OCTREOTIDE PRETREATMENT ON SURGICAL OUTCOME IN ACROMEGALY
    The Journal of clinical endocrinology and metabolism
    
    A. Colao et al., "EFFECT OF OCTREOTIDE PRETREATMENT ON SURGICAL OUTCOME IN ACROMEGALY", The Journal of clinical endocrinology and metabolism, 82(10), 1997, pp. 3308-3314
87. CARON P; MORANGERAMOS I; COGNE M; JAQUET P
    3-YEAR FOLLOW-UP OF ACROMEGALIC PATIENTS TREATED WITH INTRAMUSCULAR SLOW-RELEASE LANREOTIDE
    The Journal of clinical endocrinology and metabolism
    
    P. Caron et al., "3-YEAR FOLLOW-UP OF ACROMEGALIC PATIENTS TREATED WITH INTRAMUSCULAR SLOW-RELEASE LANREOTIDE", The Journal of clinical endocrinology and metabolism, 82(1), 1997, pp. 18-22
88. TITTOBELLO A
    DIAGNOSIS AND PREVENTION OF POST-ERCP PANCREATITIS
    Endoscopy
    
    A. Tittobello, "DIAGNOSIS AND PREVENTION OF POST-ERCP PANCREATITIS", Endoscopy, 29(4), 1997, pp. 285-287
89. FREEMAN ML
    COMPLICATIONS OF ENDOSCOPIC BILIARY SPHINCTEROTOMY - A REVIEW
    Endoscopy
    
    M.L. Freeman, "COMPLICATIONS OF ENDOSCOPIC BILIARY SPHINCTEROTOMY - A REVIEW", Endoscopy, 29(4), 1997, pp. 288-297
90. GILLIS JC; NOBLE S; GOA KL
    OCTREOTIDE LONG-ACTING RELEASE (LAR) - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN THE MANAGEMENT OF ACROMEGALY
    Drugs
    
    J.C. Gillis et al., "OCTREOTIDE LONG-ACTING RELEASE (LAR) - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN THE MANAGEMENT OF ACROMEGALY", Drugs, 53(4), 1997, pp. 681-699
91. GORGES R; CORDES U; ENGELBACH M; BARTELT KM; HABERERN G; HEY O; BEYER J; BOCKISCH A
    PREDICTION OF THE PHARMACOLOGICAL EFFECT OF OCTREOTIDE IN ACROMEGALY BY MEANS OF IN-111-PENTETREOTIDE SCINTIGRAPHY AND CALCULATION OF A PITUITARY UPTAKE INDEX
    Nuklearmedizin
    
    R. Gorges et al., "PREDICTION OF THE PHARMACOLOGICAL EFFECT OF OCTREOTIDE IN ACROMEGALY BY MEANS OF IN-111-PENTETREOTIDE SCINTIGRAPHY AND CALCULATION OF A PITUITARY UPTAKE INDEX", Nuklearmedizin, 36(4), 1997, pp. 117-124
92. VIRALLYMONOD ML; GUILLAUSSEAU PJ; ASSAYAG M; TIELMANS D; AJZENBERG C; VASSEURMALLUS S; IMBERTY C; WARNET A
    VARIABLE EFFICACY OF OCTREOTIDE IN DIABETIC DIARRHEA
    Diabetes & metabolism
    
    M.L. Virallymonod et al., "VARIABLE EFFICACY OF OCTREOTIDE IN DIABETIC DIARRHEA", Diabetes & metabolism, 22(5), 1996, pp. 356-358
93. WEEKES LM; HO KK; SEALE JP
    TREATMENT OPTIONS IN ACROMEGALY - BENEFITS AND COSTS
    PharmacoEconomics
    
    L.M. Weekes et al., "TREATMENT OPTIONS IN ACROMEGALY - BENEFITS AND COSTS", PharmacoEconomics, 10(5), 1996, pp. 453-459
94. BAILLIEJOHNSON HR
    OCTREOTIDE IN THE MANAGEMENT OF TREATMENT-RELATED DIARRHEA
    Anti-cancer drugs
    
    H.R. Bailliejohnson, "OCTREOTIDE IN THE MANAGEMENT OF TREATMENT-RELATED DIARRHEA", Anti-cancer drugs, 7, 1996, pp. 11-15
95. TESTONI PA; LELLA F; BAGNOLO F; CAPORUSCIO S; CATTANI L; COLOMBO E; BUIZZA M
    LONG-TERM PROPHYLACTIC ADMINISTRATION OF OCTREOTIDE REDUCES THE RISE IN SERUM AMYLASE AFTER ENDOSCOPIC PROCEDURES ON VATERS PAPILLA
    Pancreas
    
    P.A. Testoni et al., "LONG-TERM PROPHYLACTIC ADMINISTRATION OF OCTREOTIDE REDUCES THE RISE IN SERUM AMYLASE AFTER ENDOSCOPIC PROCEDURES ON VATERS PAPILLA", Pancreas, 13(1), 1996, pp. 61-65
96. INVITTI C; FATTI L; CAMBONI MG; PORCU L; DANESI L; DELITALA G; CAVAGNINI F
    EFFECT OF CHRONIC TREATMENT WITH OCTREOTIDE NASAL POWDER ON SERUM LEVELS OF GROWTH-HORMONE, INSULIN-LIKE GROWTH-FACTOR-I, INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEIN-1 AND BINDING-PROTEIN-3 IN ACROMEGALIC PATIENTS
    Journal of endocrinological investigation
    
    C. Invitti et al., "EFFECT OF CHRONIC TREATMENT WITH OCTREOTIDE NASAL POWDER ON SERUM LEVELS OF GROWTH-HORMONE, INSULIN-LIKE GROWTH-FACTOR-I, INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEIN-1 AND BINDING-PROTEIN-3 IN ACROMEGALIC PATIENTS", Journal of endocrinological investigation, 19(8), 1996, pp. 548-555
97. DIFRANCESCO V; ANGELINI G; BOVO P; CASARINI MB; FILIPPINI M; VAONA B; FRULLONI L; RIGO L; BRUNORI MP; CAVALLINI G
    EFFECT OF OCTREOTIDE ON SPHINCTER OF ODDI MOTILITY IN PATIENTS WITH ACUTE RECURRENT PANCREATITIS - A MANOMETRIC STUDY
    Digestive diseases and sciences
    
    V. Difrancesco et al., "EFFECT OF OCTREOTIDE ON SPHINCTER OF ODDI MOTILITY IN PATIENTS WITH ACUTE RECURRENT PANCREATITIS - A MANOMETRIC STUDY", Digestive diseases and sciences, 41(12), 1996, pp. 2392-2396
98. CAVALLINI G; TITTOBELLO A; FRULLONI L; MASCI E; MARIANI A; DIFRANCESCO V; ANGELINI GP; CASARINI MB; BEDOGNI G; CONIGLIARO R; BONARDI L; KHAJEKINI MTA; CIPOLLETTA L; BIANCO MA; COSTAMAGNA G; PERRI V; DOBRILLA G; DEPRETIS G; FAMILIARI L; GIACOBBE G; FRATTON A; CARONE N; LORIGA P; MUSCAS A; MAZZEO F; GAETA L; MIGLIOLI M; PEZZILLI R; MORELLI A; SANTUCCI L; NACCARATO R; DELFAVERO G; ORLANDI F; MACARRI GP; RUSSO A; VIRGILIO C; UOMO G; MANES G
    GABEXATE FOR THE PREVENTION OF PANCREATIC DAMAGE RELATED TO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY
    The New England journal of medicine
    
    G. Cavallini et al., "GABEXATE FOR THE PREVENTION OF PANCREATIC DAMAGE RELATED TO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY", The New England journal of medicine, 335(13), 1996, pp. 919-923
99. FREEMAN R; YOUNG J; LANDSBERG L; LIPSITZ L
    THE TREATMENT OF POSTPRANDIAL HYPOTENSION IN AUTONOMIC FAILURE WITH 3,4-DL-THREO-DIHYDROXYPHENYLSERINE
    Neurology
    
    R. Freeman et al., "THE TREATMENT OF POSTPRANDIAL HYPOTENSION IN AUTONOMIC FAILURE WITH 3,4-DL-THREO-DIHYDROXYPHENYLSERINE", Neurology, 47(6), 1996, pp. 1414-1420
100. ROBBINS RJ
     SOMATOSTATIN AND CANCER
     Metabolism, clinical and experimental
     
     R.J. Robbins, "SOMATOSTATIN AND CANCER", Metabolism, clinical and experimental, 45(8), 1996, pp. 98-100